Literature DB >> 27060227

Generation of Novel Thyroid Cancer Stem-Like Cell Clones: Effects of Resveratrol and Valproic Acid.

Heather Hardin1, Xiao-Min Yu2, April D Harrison2, Carolina Larrain1, Ranran Zhang1, Jidong Chen1, Herbert Chen3, Ricardo V Lloyd4.   

Abstract

Anaplastic thyroid cancer is an aggressive and highly lethal cancer for which conventional therapies have proved ineffective. Cancer stem-like cells (CSCs) represent a small fraction of cells in the cancer that are resistant to chemotherapy and radiation therapy and are responsible for tumor reoccurrence and metastasis. We characterized CSCs in thyroid carcinomas and generated clones of CSC lines. Our study showed that anaplastic thyroid cancers had significantly more CSCs than well-differentiated thyroid cancers. We also showed that Aldefluor-positive cells revealed significantly higher expression of stem cell markers, self-renewal properties, thyrosphere formation, and enhanced tumorigenicity. In vivo passaging of Aldefluor-positive cells resulted in the growth of larger, more aggressive tumors. We isolated and generated two clonal spheroid CSC lines derived from anaplastic thyroid cancer that were even more enriched with stem cell markers and more tumorigenic than the freshly isolated Aldefluor-positive cells. Resveratrol and valproic acid treatment of one of the CSC lines resulted in a significant decrease in stem cell markers, Aldefluor expression, proliferation, and invasiveness, with an increase in apoptosis and thyroid differentiation markers, suggesting that these cell lines may be useful for discovering new adjuvant therapies for aggressive thyroid cancers. For the first time, we have two thyroid CSC lines that will be useful tools for the study of thyroid CSC targeted therapies.
Copyright © 2016 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27060227      PMCID: PMC6136064          DOI: 10.1016/j.ajpath.2016.02.003

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

1.  Korea's thyroid-cancer "epidemic"--screening and overdiagnosis.

Authors:  Hyeong Sik Ahn; Hyun Jung Kim; H Gilbert Welch
Journal:  N Engl J Med       Date:  2014-11-06       Impact factor: 91.245

Review 2.  Cancer stem cell hypothesis in thyroid cancer.

Authors:  Ping Zhang; Hui Zuo; Takashi Ozaki; Nami Nakagomi; Kennichi Kakudo
Journal:  Pathol Int       Date:  2006-09       Impact factor: 2.534

3.  Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas.

Authors:  Darya Buehler; Heather Hardin; Weihua Shan; Celina Montemayor-Garcia; Patrick S Rush; Sofia Asioli; Herbert Chen; Ricardo V Lloyd
Journal:  Mod Pathol       Date:  2012-08-17       Impact factor: 7.842

4.  Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients.

Authors:  Cristina Raimondi; Angela Gradilone; Giuseppe Naso; Bruno Vincenzi; Arianna Petracca; Chiara Nicolazzo; Antonella Palazzo; Rosa Saltarelli; Franco Spremberg; Enrico Cortesi; Paola Gazzaniga
Journal:  Breast Cancer Res Treat       Date:  2011-02-05       Impact factor: 4.872

Review 5.  Thyroid cancer stem cells.

Authors:  Reigh-Yi Lin
Journal:  Nat Rev Endocrinol       Date:  2011-07-26       Impact factor: 43.330

Review 6.  Clinical review: The emerging cell biology of thyroid stem cells.

Authors:  Terry F Davies; Rauf Latif; Noga C Minsky; Risheng Ma
Journal:  J Clin Endocrinol Metab       Date:  2011-07-21       Impact factor: 5.958

7.  Histone deacetylase inhibitors restore radioiodide uptake and retention in poorly differentiated and anaplastic thyroid cancer cells by expression of the sodium/iodide symporter thyroperoxidase and thyroglobulin.

Authors:  Fumihiko Furuya; Hiroki Shimura; Hideyo Suzuki; Katsumi Taki; Kazuyasu Ohta; Kazutaka Haraguchi; Toshimasa Onaya; Toyoshi Endo; Tetsuro Kobayashi
Journal:  Endocrinology       Date:  2004-02-19       Impact factor: 4.736

8.  Raf-1 activation suppresses neuroendocrine marker and hormone levels in human gastrointestinal carcinoid cells.

Authors:  Rebecca S Sippel; Jennifer E Carpenter; Muthusamy Kunnimalaiyaan; Sara Lagerholm; Herbert Chen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-08       Impact factor: 4.052

9.  Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth.

Authors:  Xiao-Min Yu; Renata Jaskula-Sztul; Kamal Ahmed; April D Harrison; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Mol Cancer Ther       Date:  2013-04-17       Impact factor: 6.261

10.  Stemness in human thyroid cancers and derived cell lines: the role of asymmetrically dividing cancer stem cells resistant to chemotherapy.

Authors:  Risheng Ma; Noga Minsky; Syed A Morshed; Terry F Davies
Journal:  J Clin Endocrinol Metab       Date:  2014-02-25       Impact factor: 5.958

View more
  12 in total

Review 1.  Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs.

Authors:  James A McCubrey; Kvin Lertpiriyapong; Linda S Steelman; Steve L Abrams; Li V Yang; Ramiro M Murata; Pedro L Rosalen; Aurora Scalisi; Luca M Neri; Lucio Cocco; Stefano Ratti; Alberto M Martelli; Piotr Laidler; Joanna Dulińska-Litewka; Dariusz Rakus; Agnieszka Gizak; Paolo Lombardi; Ferdinando Nicoletti; Saverio Candido; Massimo Libra; Giuseppe Montalto; Melchiorre Cervello
Journal:  Aging (Albany NY)       Date:  2017-06-12       Impact factor: 5.682

2.  Long Non-coding RNA Expression in Anaplastic Thyroid Carcinomas.

Authors:  Yanping Wang; Heather Hardin; Ying-Hsia Chu; Karla Esbona; Ranran Zhang; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2019-12       Impact factor: 3.943

3.  Phosphorylated Mechanistic Target of Rapamycin (p-mTOR) and Noncoding RNA Expression in Follicular and Hürthle Cell Thyroid Neoplasm.

Authors:  Adam Covach; Sanjay Patel; Heather Hardin; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2017-09       Impact factor: 3.943

4.  Stage-Specific Embryonic Antigen-1 (SSEA-1) Expression in Thyroid Tissues.

Authors:  Jin Xu; Heather Hardin; Ranran Zhang; Kaitlin Sundling; Darya Buehler; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2016-12       Impact factor: 3.943

5.  MALAT1 Long Non-coding RNA Expression in Thyroid Tissues: Analysis by In Situ Hybridization and Real-Time PCR.

Authors:  Ranran Zhang; Heather Hardin; Wei Huang; Jidong Chen; Sofia Asioli; Alberto Righi; Francesca Maletta; Anna Sapino; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2017-03       Impact factor: 3.943

Review 6.  Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review.

Authors:  Heewa Shakib; Sadegh Rajabi; Mohammad Hossien Dehghan; Farideh Jalali Mashayekhi; Nahid Safari-Alighiarloo; Mehdi Hedayati
Journal:  Endocrine       Date:  2019-08-04       Impact factor: 3.633

Review 7.  Sonic Hedgehog Signaling in Thyroid Cancer.

Authors:  Xiulong Xu; Yurong Lu; Yi Li; Richard A Prinz
Journal:  Front Endocrinol (Lausanne)       Date:  2017-10-30       Impact factor: 5.555

8.  Thyroid cancer stem-like cell exosomes: regulation of EMT via transfer of lncRNAs.

Authors:  Heather Hardin; Holly Helein; Kristy Meyer; Samantha Robertson; Ranran Zhang; Weixiong Zhong; Ricardo V Lloyd
Journal:  Lab Invest       Date:  2018-07-02       Impact factor: 5.662

Review 9.  Therapeutic advances in anaplastic thyroid cancer: a current perspective.

Authors:  Shikha Saini; Kiara Tulla; Ajay V Maker; Kenneth D Burman; Bellur S Prabhakar
Journal:  Mol Cancer       Date:  2018-10-23       Impact factor: 27.401

Review 10.  Herbal Active Ingredients: An Emerging Potential for the Prevention and Treatment of Papillary Thyroid Carcinoma.

Authors:  Yang Yang; Qin Chen; Wen-Ying Yu; Huan-Huan Zhang; Yu-Sen Zhong; Song-Zhao Zhang; Jia-Feng Wang; Chen-Huan Yu
Journal:  Biomed Res Int       Date:  2020-01-31       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.